Total Payments
$3,159
2024 Payments
$634.97
Companies
19
Transactions
101
Medicare Patients
3,178
Medicare Billing
$629,302
Payment Breakdown by Category
Food & Beverage$2,953 (93.5%)
Education$206.41 (6.5%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $2,953 | 86 | 93.5% |
| Education | $206.41 | 15 | 6.5% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Aurinia Pharma U.S., Inc. | $448.90 | 17 | $0 (2024) |
| AstraZeneca Pharmaceuticals LP | $380.38 | 12 | $0 (2024) |
| Fresenius USA Marketing, Inc. | $325.45 | 16 | $0 (2024) |
| NxStage Medical, Inc. | $270.27 | 2 | $0 (2023) |
| Otsuka America Pharmaceutical, Inc. | $257.83 | 10 | $0 (2024) |
| Ardelyx, Inc. | $244.06 | 6 | $0 (2024) |
| Bayer Healthcare Pharmaceuticals Inc. | $209.23 | 7 | $0 (2024) |
| OPKO Pharmaceuticals, LLC | $171.25 | 10 | $0 (2024) |
| Travere Therapeutics, Inc. | $163.34 | 6 | $0 (2024) |
| Medtronic, Inc. | $125.13 | 1 | $0 (2022) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $634.97 | 26 | Ardelyx, Inc. ($219.42) |
| 2023 | $1,002 | 33 | AstraZeneca Pharmaceuticals LP ($164.03) |
| 2022 | $1,032 | 28 | Aurinia Pharma U.S., Inc. ($181.66) |
| 2021 | $248.48 | 12 | Aurinia Pharma U.S., Inc. ($103.34) |
| 2020 | $118.81 | 1 | Janssen Pharmaceuticals, Inc ($118.81) |
| 2019 | $121.92 | 1 | Relypsa, Inc. ($121.92) |
All Payment Transactions
101 individual payment records from CMS Open Payments — Page 1 of 5
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/19/2024 | Ardelyx, Inc. | IBSRELA (Drug) | Food and Beverage | In-kind items and services | $30.99 | General |
| Category: GASTROENTEROLOGY | ||||||
| 12/16/2024 | AKEBIA THERAPEUTICS INC | Vafseo (Drug) | Education | In-kind items and services | $24.61 | General |
| Category: Nephrology | ||||||
| 12/05/2024 | CALLIDITAS THERAPEUTICS US INC. | TARPEYO (Drug) | Food and Beverage | In-kind items and services | $19.32 | General |
| Category: Nephrology | ||||||
| 12/05/2024 | Otsuka America Pharmaceutical, Inc. | JYNARQUE (Drug) | Food and Beverage | In-kind items and services | $17.09 | General |
| Category: NEPHROLOGY | ||||||
| 11/27/2024 | CorMedix Inc. | DefenCath (Drug) | Food and Beverage | In-kind items and services | $28.46 | General |
| Category: Catheter Lock Solution | ||||||
| 11/21/2024 | Travere Therapeutics, Inc. | — | Food and Beverage | In-kind items and services | $23.29 | General |
| 11/21/2024 | Otsuka America Pharmaceutical, Inc. | JYNARQUE (Drug) | Food and Beverage | In-kind items and services | $13.82 | General |
| Category: NEPHROLOGY | ||||||
| 11/11/2024 | Bayer Healthcare Pharmaceuticals Inc. | Kerendia (Drug) | Food and Beverage | In-kind items and services | $22.62 | General |
| Category: Cardio-renal | ||||||
| 11/07/2024 | Ardelyx, Inc. | IBSRELA (Drug) | Food and Beverage | In-kind items and services | $25.01 | General |
| Category: GASTROENTEROLOGY | ||||||
| 10/24/2024 | Aurinia Pharma U.S., Inc. | LUPKYNIS (Drug) | Food and Beverage | In-kind items and services | $26.22 | General |
| Category: LUPUS NEPHRITIS | ||||||
| 10/03/2024 | Otsuka America Pharmaceutical, Inc. | JYNARQUE (Drug) | Food and Beverage | In-kind items and services | $16.19 | General |
| Category: NEPHROLOGY | ||||||
| 08/22/2024 | Novartis Pharmaceuticals Corporation | — | Food and Beverage | In-kind items and services | $24.91 | General |
| 07/18/2024 | Otsuka America Pharmaceutical, Inc. | JYNARQUE (Drug) | Food and Beverage | In-kind items and services | $20.58 | General |
| Category: NEPHROLOGY | ||||||
| 06/20/2024 | OPKO Pharmaceuticals, LLC | RAYALDEE (Drug) | Education | In-kind items and services | $15.28 | General |
| Category: NEPHROLOGY | ||||||
| 06/03/2024 | Fresenius USA Marketing, Inc. | Velphoro (Drug) | Food and Beverage | In-kind items and services | $21.12 | General |
| Category: Phosphate binder for ESRD | ||||||
| 05/28/2024 | Travere Therapeutics, Inc. | — | Education | In-kind items and services | $3.08 | General |
| 05/16/2024 | Aurinia Pharma U.S., Inc. | LUPKYNIS (Drug) | Food and Beverage | In-kind items and services | $28.85 | General |
| Category: LUPUS NEPHRITIS | ||||||
| 04/19/2024 | Ardelyx, Inc. | IBSRELA (Drug) | Food and Beverage | In-kind items and services | $31.59 | General |
| Category: GASTROENTEROLOGY | ||||||
| 04/16/2024 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $15.42 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 04/08/2024 | Fresenius USA Marketing, Inc. | Velphoro (Drug) | Food and Beverage | In-kind items and services | $22.93 | General |
| Category: Phosphate binder for ESRD | ||||||
| 03/07/2024 | Fresenius USA Marketing, Inc. | Velphoro (Drug) | Food and Beverage | In-kind items and services | $22.53 | General |
| Category: Phosphate binder for ESRD | ||||||
| 02/16/2024 | Ardelyx, Inc. | IBSRELA (Drug) | Food and Beverage | In-kind items and services | $27.59 | General |
| Category: GASTROENTEROLOGY | ||||||
| 02/15/2024 | Otsuka America Pharmaceutical, Inc. | JYNARQUE (Drug) | Food and Beverage | In-kind items and services | $13.89 | General |
| Category: NEPHROLOGY | ||||||
| 02/06/2024 | Fresenius USA Marketing, Inc. | Velphoro (Drug) | Food and Beverage | In-kind items and services | $19.10 | General |
| Category: Phosphate binder for ESRD | ||||||
| 02/01/2024 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $16.24 | General |
| Category: Cardiovascular and Metabolism | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 9 | 730 | 2,327 | $299,748 | $174,063 |
| 2022 | 8 | 730 | 2,269 | $272,998 | $152,844 |
| 2021 | 9 | 795 | 2,198 | $261,735 | $146,323 |
| 2020 | 8 | 923 | 2,279 | $277,125 | $156,072 |
Total Patients
3,178
Total Services
9,073
Medicare Billing
$629,302
Procedure Codes
36
All Medicare Procedures & Services
36 procedure records from CMS Medicare Utilization — Page 1 of 2
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99232 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes | Facility | 2023 | 320 | 1,605 | $155,685 | $94,211 | 60.5% |
| 99223 | Initial hospital care with moderate level of medical decision making, if using time, at least 75 minutes | Facility | 2023 | 150 | 163 | $45,151 | $20,916 | 46.3% |
| 90961 | Dialysis services, 2-3 physician visits per month (20 years or older) | Facility | 2023 | 21 | 82 | $31,160 | $17,513 | 56.2% |
| 90935 | Hemodialysis procedure with physician evaluation | Facility | 2023 | 62 | 207 | $19,665 | $10,976 | 55.8% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 59 | 106 | $13,823 | $9,581 | 69.3% |
| 90966 | Home dialysis services per month (20 years or older) | Facility | 2023 | 16 | 35 | $11,305 | $7,616 | 67.4% |
| 99222 | Initial hospital care with straightforward or low-level medical decision making, if using time, at least 55 minutes | Facility | 2023 | 47 | 66 | $11,682 | $6,374 | 54.6% |
| 99233 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 50 minutes | Facility | 2023 | 37 | 45 | $6,705 | $3,986 | 59.4% |
| 99205 | New patient office or other outpatient visit, 60-74 minutes | Office | 2023 | 18 | 18 | $4,572 | $2,892 | 63.3% |
| 99232 | Follow-up hospital inpatient care per day, typically 25 minutes | Facility | 2022 | 345 | 1,653 | $160,341 | $87,346 | 54.5% |
| 99223 | Initial hospital inpatient care per day, typically 70 minutes | Facility | 2022 | 140 | 140 | $38,813 | $20,304 | 52.3% |
| 90966 | Home dialysis services per month (20 years or older) | Facility | 2022 | 16 | 55 | $17,765 | $12,301 | 69.2% |
| 90935 | Hemodialysis procedure with physician evaluation | Facility | 2022 | 62 | 193 | $18,335 | $10,594 | 57.8% |
| 99222 | Initial hospital inpatient care per day, typically 50 minutes | Facility | 2022 | 58 | 77 | $13,691 | $7,693 | 56.2% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 33 | 53 | $6,943 | $4,874 | 70.2% |
| 99205 | New patient office or other outpatient visit, 60-74 minutes | Office | 2022 | 27 | 27 | $6,925 | $4,365 | 63.0% |
| 99233 | Follow-up hospital inpatient care per day, typically 35 minutes | Facility | 2022 | 35 | 44 | $6,556 | $3,373 | 51.4% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Facility | 2022 | 14 | 27 | $3,629 | $1,994 | 54.9% |
| 99232 | Subsequent hospital inpatient care, typically 25 minutes per day | Facility | 2021 | 382 | 1,615 | $156,655 | $87,526 | 55.9% |
| 99223 | Initial hospital inpatient care, typically 70 minutes per day | Facility | 2021 | 190 | 206 | $56,882 | $30,857 | 54.2% |
| 99233 | Subsequent hospital inpatient care, typically 35 minutes per day | Facility | 2021 | 83 | 127 | $18,923 | $9,865 | 52.1% |
| 90935 | Hemodialysis procedure with one physician evaluation | Facility | 2021 | 59 | 133 | $12,635 | $7,413 | 58.7% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 22 | 43 | $5,703 | $4,012 | 70.4% |
| 99222 | Initial hospital inpatient care, typically 50 minutes per day | Facility | 2021 | 18 | 19 | $3,363 | $1,950 | 58.0% |
| 99205 | New patient outpatient visit, total time 60-74 minutes | Office | 2021 | 13 | 13 | $3,302 | $1,784 | 54.0% |
About Dr. Vijaya Kumar Gorantla, M.D
Dr. Vijaya Kumar Gorantla, M.D is a Nephrology healthcare provider based in Memphis, Tennessee. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 04/04/2012. The National Provider Identifier (NPI) number assigned to this provider is 1679839666.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Vijaya Kumar Gorantla, M.D has received a total of $3,159 in payments from pharmaceutical and medical device companies, with $634.97 received in 2024. These payments were reported across 101 transactions from 19 companies. The most common payment nature is "Food and Beverage" ($2,953).
As a Medicare-enrolled provider, Gorantla has provided services to 3,178 Medicare beneficiaries, totaling 9,073 services with total Medicare billing of $629,302. Data is available for 4 years (2020–2023), covering 36 distinct procedure/service records.
Ad
Practice Information
- Specialty Nephrology
- Location Memphis, TN
- Active Since 04/04/2012
- Last Updated 10/21/2020
- Taxonomy Code 207RN0300X
- Entity Type Individual
- NPI Number 1679839666
Products in Payments
- LUPKYNIS (Drug) $448.90
- Velphoro (Drug) $325.45
- FARXIGA (Drug) $315.68
- LIBERTY SELECT CYCLER (Device) $270.27
- JYNARQUE (Drug) $257.83
- Kerendia (Drug) $209.23
- RAYALDEE (Drug) $171.25
- Veltassa (Drug) $147.24
- IBSRELA (Drug) $139.82
- ELLIPSYS VASCULAR ACCESS SYSTEM (Device) $125.13
- INVOKANA (Drug) $118.81
- XPHOZAH 30 MG (Drug) $104.24
- Envarsus (Drug) $95.84
- LOKELMA (Drug) $64.70
- Parsabiv (Drug) $62.65
- TARPEYO (Drug) $34.38
- DefenCath (Drug) $28.46
- Vafseo (Drug) $24.61
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Nephrology Doctors in Memphis
Dr. Omar Davis, M.d, M.D
Nephrology — Payments: $57,405
Nephrology $57,405
Dr. Natarsha Grant, Md, MD
Nephrology — Payments: $34,340
Nephrology $34,340
Dr. Robert Canada, Md, MD
Nephrology — Payments: $21,903
Nephrology $21,903
Dr. Wael Hussein
Nephrology — Payments: $15,498
Nephrology $15,498
Minesh Pathak, M.d, M.D
Nephrology — Payments: $13,583
Nephrology $13,583
L Quarles, M.d, M.D
Nephrology — Payments: $12,060
Nephrology $12,060